Control of relapsed germ cell tumor and SLE nephritis by high-dose chemotherapy and autologous hematopoietic cell transplantation

被引：0
作者：
Kosmas, Christos [1 ,2 ]
Papachrysanthou, Theodora [1 ,2 ]
Daladimos, Theodoros [1 ,2 ]
Athanasopoulos, Aggelos [3 ,4 ]
Tsavaris, Nicolas [5 ]
Vlachoyiannopoulos, Panayiotis G. [5 ]
机构：
[1] Metaxa Canc Hosp, Dept Med, Div Med Oncol 2, Piraeus, Greece
[2] Metaxa Canc Hosp, Hematopoiet Cell Transplantat Program, Piraeus, Greece
[3] Metaxa Canc Hosp, Dept Transfus Med, Piraeus, Greece
[4] Metaxa Canc Hosp, Stem Cell Proc Lab, Piraeus, Greece
[5] Univ Athens, Sch Med, Laikon Gen Hosp, Dept Pathophysiol,Oncol Unit, GR-11527 Athens, Greece
来源：
FUTURE ONCOLOGY | 2013年 / 9卷 / 09期
关键词：
germ cell tumor; hematopoietic cell transplantation; high-dose chemotherapy; systemic lupus erythematosus; BONE-MARROW-TRANSPLANTATION; SYSTEMIC-LUPUS-ERYTHEMATOSUS; SALVAGE TREATMENT; RANDOMIZED-TRIAL; RHEUMATOID-ARTHRITIS; RESCUE; PACLITAXEL; SUPERIOR; CANCER;
D O I：
10.2217/fon.13.70
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
High-dose chemotherapy and hematopoietic stem cell support remains a curative treatment option for relapsed or nonresponsive germ cell tumors, and has been applied experimentally to control severe autoimmune diseases. In the present study, we report on a patient with systemic lupus erythematosus nephritis who developed a nonseminomatous germ cell tumor that relapsed after standard chemotherapy and surgery. The patient received high-dose chemotherapy supported by autologous hematopoietic cell transplantation based on its indication for relapsed germ cell tumors. Prolonged control of his relapsed germ cell tumor and systemic lupus erythematosus was attained with high-dose chemotherapy and hematopoietic stem cell support. An extensive literature review is provided alongside a detailed discussion of the aforementioned case.
引用
收藏
页码：1401 / 1406
页数：6
相关论文
共 28 条
[1]   Depletion of autoreactive immunologic memory followed by autologous hematopoietic stem cell transplantation in patients with refractory SLE induces long-term remission through de novo generation of a juvenile and tolerant immune system [J].
Alexander, Tobias ;
Thiel, Andreas ;
Rosen, Oliver ;
Massenkeil, Gero ;
Sattler, Arne ;
Kohler, Siegfried ;
Mei, Henrik ;
Radtke, Hartmut ;
Gromnica-Ihle, Erika ;
Burmester, Gerd-Ruediger ;
Arnold, Renate ;
Radbruch, Andreas ;
Hiepe, Falk .
BLOOD, 2009, 113 (01) :214-223
[2]   Metastatic germ cell tumors: Modeling for response to chemotherapy [J].
Bajorin, DF ;
Mazumdar, M ;
Meyers, M ;
Motzer, RJ ;
Vlamis, V ;
Lin, P ;
Bosl, GJ .
JOURNAL OF CLINICAL ONCOLOGY, 1998, 16 (02) :707-715
[3]   FDG PET is superior to CT in the prediction of viable tumour in post-chemotherapy seminoma residuals [J].
Becherer, A ;
De Santis, M ;
Karanikas, G ;
Szabó, M ;
Bokemeyer, C ;
Dohmen, BM ;
Pont, J ;
Dudczak, R ;
Dittrich, C ;
Kletter, K .
EUROPEAN JOURNAL OF RADIOLOGY, 2005, 54 (02) :284-288
[4]   Prognostic Factors in Patients With Metastatic Germ Cell Tumors Who Experienced Treatment Failure With Cisplatin-Based First-Line Chemotherapy [J].
Beyer, Joerg ;
Lorch, Anja ;
Beyer, Joerg ;
Bascoul-Mollevi, C. ;
Kramar, A. ;
Einhorn, Lawrence H. ;
Necchi, A. ;
Massard, C. ;
De Giorgi, U. ;
Flechon, A. ;
Margolin, Kim A. ;
Lotz, Jean-Pierre ;
Lluch, Jose Ramon Germa ;
Powles, Thomas ;
Kollmannsberger, Christian K. .
JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (33) :4906-4911
[5]   Nonmyeloablative hematopoietic stem cell transplantation for systemic lupus erythematosus [J].
Burt, RK ;
Traynor, A ;
Statkute, L ;
Barr, WG ;
Rosa, R ;
Schroeder, J ;
Verda, L ;
Krosnjar, N ;
Quigley, K ;
Yaung, K ;
Villa, M ;
Takahashi, M ;
Jovanovic, B ;
Oyama, Y .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2006, 295 (05) :527-535
[6]   Hematopoietic Stem Cell Transplantation for Systemic Lupus Erythematosus [J].
Champ, Alberto M. Marmont du Haut .
CLINICAL & DEVELOPMENTAL IMMUNOLOGY, 2012,
[7]   High-dose chemotherapy and stem-cell rescue for metastatic germ-cell tumors [J].
Einhorn, Lawrence H. ;
Williams, Stephen D. ;
Chamness, Amy ;
Brames, Mary J. ;
Perkins, Susan M. ;
Abonour, Rafat .
NEW ENGLAND JOURNAL OF MEDICINE, 2007, 357 (04) :340-348
[8]   Is High Dose Therapy Superior to Conventional Dose Therapy as Initial Treatment for Relapsed Germ Cell Tumors? The TIGER Trial [J].
Feldman, Darren R. ;
Huddart, Robert ;
Hall, Emma ;
Beyer, Joerg ;
Powles, Thomas .
JOURNAL OF CANCER, 2011, 2 :374-377
[9]   Tolerance induction by bone marrow transplantation in a multiple sclerosis model [J].
Herrmann, MM ;
Gaertner, S ;
Stadelmann, C ;
van den Brandt, J ;
Böscke, R ;
Budach, W ;
Reichardt, HM ;
Weissert, R .
BLOOD, 2005, 106 (05) :1875-1883
[10]   RATIONALE FOR BONE-MARROW TRANSPLANTATION IN THE TREATMENT OF AUTOIMMUNE-DISEASES [J].
IKEHARA, S ;
GOOD, RA ;
NAKAMURA, T ;
SEKITA, K ;
INOUE, S ;
OO, MM ;
MUSO, E ;
OGAWA, K ;
HAMASHIMA, Y .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1985, 82 (08) :2483-2487
123